Platelet-Derived Growth Factor as an Antidepressant Treatment Selection Biomarker: Higher Levels Selectively Predict Better Outcomes with Bupropion-SSRI Combination

BACKGROUND: Platelet derived growth factor is integral to maintenance of blood brain barrier, increases in response to blood brain barrier disruption, and may reflect neuroinflammation. Based on previous reports of better outcomes with dopaminergic antidepressants in depressed patients with elevated...

Descripción completa

Detalles Bibliográficos
Autores principales: Jha, Manish K, Minhajuddin, Abu, Gadad, Bharathi S, Trivedi, Madhukar H
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2017
Materias:
Regular Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5737519/
https://www.ncbi.nlm.nih.gov/pubmed/29016822
http://dx.doi.org/10.1093/ijnp/pyx060

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5737519/
https://www.ncbi.nlm.nih.gov/pubmed/29016822
http://dx.doi.org/10.1093/ijnp/pyx060

Ejemplares similares